The Philadelphia (Ph)-chromosome, or translocation t (9; 22), has been recognized as the hallmark of CML [3], and the BCR-ABL1 fusion gene has subsequently been identified as the key participant in the pathophysiology of CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.